Published in Antiviral Res on December 15, 1999
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
IRES-driven translation is stimulated separately by the FMDV 3'-NCR and poly(A) sequences. Nucleic Acids Res (2002) 1.09
Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. J Virol (2007) 0.97
Exploring IRES region accessibility by interference of foot-and-mouth disease virus infectivity. PLoS One (2012) 0.80
Multiple microRNAs targeted to internal ribosome entry site against foot-and-mouth disease virus infection in vitro and in vivo. Virol J (2014) 0.79
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04
Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol (1994) 2.41
Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol (1988) 1.90
Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol (1991) 1.89
Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol (2012) 1.80
Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J Virol (1992) 1.72
Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1989) 1.71
Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res (2001) 1.70
Involvement of the ftsA gene product in late stages of the Escherichia coli cell cycle. J Bacteriol (1980) 1.66
Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem (1999) 1.59
A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol (1990) 1.57
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol (2001) 1.56
Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53
Interaction of the eIF4G initiation factor with the aphthovirus IRES is essential for internal translation initiation in vivo. RNA (2000) 1.51
Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J (1984) 1.49
Aedes aegypti (Diptera: Culicidae) production from non-residential sites in the Amazonian city of Iquitos, Peru. Ann Trop Med Parasitol (2006) 1.49
Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med (1999) 1.45
Conserved structural motifs located in distal loops of aphthovirus internal ribosome entry site domain 3 are required for internal initiation of translation. J Virol (1997) 1.38
Relationship of Escherichia coli density to growth rate and cell age. J Bacteriol (1981) 1.38
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36
Amber mutation affecting the length of Escherichia coli cells. J Bacteriol (1980) 1.30
IRES interaction with translation initiation factors: functional characterization of novel RNA contacts with eIF3, eIF4B, and eIF4GII. RNA (2001) 1.30
A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol (2001) 1.29
Long-range RNA interactions between structural domains of the aphthovirus internal ribosome entry site (IRES). RNA (1999) 1.22
Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro. J Virol (1987) 1.18
Involvement of the aphthovirus RNA region located between the two functional AUGs in start codon selection. Virology (1999) 1.16
Design of primers for PCR amplification of highly variable genomes. Comput Appl Biosci (1993) 1.16
Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene (1988) 1.12
VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10
Sequence of the viral replicase gene from foot-and-mouth disease virus C1-Santa Pau (C-S8). Gene (1985) 1.10
Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol (1991) 1.07
Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution. Proc Natl Acad Sci U S A (1988) 1.05
Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology (1999) 1.02
Extensive cell heterogeneity during persistent infection with foot-and-mouth disease virus. J Virol (1989) 1.02
Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol (2001) 1.01
Microinjecting DNA into mouse ova to study DNA replication and gene expression and to produce transgenic animals. Biotechniques (1990) 1.01
Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol (1998) 1.00
Parameters influencing translational efficiency in aphthovirus IRES-based bicistronic expression vectors. Gene (1998) 0.99
Molecular evolution of aphthoviruses. Virus Genes (1995) 0.97
Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology (1990) 0.96
In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J Gen Virol (1998) 0.96
Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol (1994) 0.95
Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus. Virology (1992) 0.95
Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res (1990) 0.95
Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol (2001) 0.95
Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J Gen Virol (1992) 0.94
Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. Vaccine (2000) 0.91
Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages. Biochem J (1989) 0.90
Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res (1989) 0.90
Treatment of verrucae plana with 15% glycolic acid. Int J Dermatol (2000) 0.90
A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine. J Virol Methods (1998) 0.89
p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. J Biol Chem (1998) 0.89
A method for determining the position and size of optimal sequence regions for phylogenetic analysis. J Mol Evol (1995) 0.89
Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol (2000) 0.88
Internal initiation of translation efficiency in different hepatitis C genotypes isolated from interferon treated patients. Arch Virol (1999) 0.88
NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett (1999) 0.88
Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma. Clin Transl Oncol (2013) 0.88
Hormonal regulation of fructose 2,6-bisphosphate levels in epididymal adipose tissue of rat. FEBS Lett (1985) 0.87
Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J Gen Virol (1999) 0.87
A porcine CD8+ T cell clone with heterotypic specificity for foot-and-mouth disease virus. J Gen Virol (1996) 0.86
Fixation of mutations at the VP1 gene of foot-and-mouth disease virus. Can quasispecies define a transient molecular clock? Gene (1991) 0.86
3D gene of foot-and-mouth disease virus. Conservation by convergence of average sequences. J Mol Biol (1988) 0.86
Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Virology (1994) 0.86
Specific inhibition of aphthovirus infection by RNAs transcribed from both the 5' and the 3' noncoding regions. J Virol (1994) 0.85
Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG. Antiviral Res (1993) 0.85
Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol (2001) 0.85
Co-ordination between elongation and division in Escherichia coli mediated by the wee gene product. J Gen Microbiol (1984) 0.84
A computer program for the design of PCR primers for diagnosis of highly variable genomes. J Virol Methods (1993) 0.84
Evidence for involvement of c-Src in the anti-apoptotic action of nitric oxide in serum-deprived RINm5F cells. Cell Signal (2001) 0.83
Molecular epidemiology of foot-and-mouth disease virus type O. J Gen Virol (1993) 0.83
Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: effect of in vivo treatment, glucocorticoids and the state of activation of cells. Immunology (1991) 0.83
Estimates by computer simulation of genetic distances from comparisons of RNAse A mismatch cleavage patterns. J Virol Methods (1993) 0.83
Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection. J Gen Virol (2003) 0.82
Glucocorticoids inhibit fructose 2,6-bisphosphate synthesis in rat thymocytes. Opposite effect of cycloheximide. Biochim Biophys Acta (1991) 0.82
Modulation of phorbol ester-induced respiratory burst by vanadate, genistein, and phenylarsine oxide in mouse macrophages. Free Radic Biol Med (1995) 0.82
Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J Biol Chem (1999) 0.82
Sodium nitroprusside-induced mitochondrial apoptotic events in insulin-secreting RINm5F cells are associated with MAP kinases activation. Exp Cell Res (2001) 0.82
Stimulation of glycolysis as an activation signal in rat peritoneal macrophages. Effect of glucocorticoids on this process. Biochem J (1992) 0.82
IgE-dependent release of myeloperoxidase by neutrophils from allergic patients. Clin Exp Allergy (2001) 0.81
The effect of experimental hypothyroidism on phosphofructokinase activity and fructose 2,6-bisphosphate concentrations in rat heart. Biochem J (1987) 0.81
The inactivation of phosphorylase and activation of glycogen synthase in the adipose tissue. Eur J Biochem (1980) 0.81
Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peritoneal neutrophils. Clin Exp Immunol (2001) 0.81
Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology (1995) 0.80
Direct PCR detection of foot-and-mouth disease virus. J Virol Methods (1994) 0.80
Control of fructose 2,6-bisphosphate levels in rat macrophages by glucose and phorbol ester. FEBS Lett (1989) 0.80
An RT-PCR assay for the specific detection of classical swine fever virus in clinical samples. Vet Res (1998) 0.80
Bent DNA in the large intergenic region of wheat dwarf geminivirus. Virology (1995) 0.80
Decrease in free-radical production with age in rat peritoneal macrophages. Biochem J (1995) 0.79
Effect of prolonged fasting upon insulin and glucagon secretion from isolated rat pancreatic islets. Rev Esp Fisiol (1978) 0.79
Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain. Vaccine (1992) 0.79
Thimerosal induces calcium mobilization, fructose 2,6-bisphosphate synthesis and cytoplasmic alkalinization in rat thymus lymphocytes. Biochim Biophys Acta (1991) 0.79
A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus. J Virol Methods (1998) 0.79
Nicotinamide inhibits inducible nitric oxide synthase enzyme activity in macrophages by allowing nitric oxide to inhibit its own formation. Life Sci (1997) 0.79